Dimensional Fund Advisors
NVAX icon

Dimensional Fund Advisors’s Novavax NVAX Stock Holding History

Dimensional Fund Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$96.4K Buy
11,847
+689
+6% +$6.25K ﹤0.01% 3123
2025
Q4 		$75K Buy
+11,158
New +$84.1K ﹤0.01% 3183
2022
Q3 		– Sell
-10,513
Closed -$541K – 3514
2022
Q2 		$541K Sell
10,513
-52,359
-83% -$2.71M ﹤0.01% 3047
2022
Q1 		$4.63M Sell
62,872
-27,247
-30% -$2.43M ﹤0.01% 2558
2021
Q4 		$12.9M Sell
90,119
-180
-0.2% -$30.9K ﹤0.01% 2200
2021
Q3 		$18.7M Sell
90,299
-12,213
-12% -$2.69M 0.01% 2039
2021
Q2 		$21.8M Buy
102,512
+7,553
+8% +$1.38M 0.01% 2014
2021
Q1 		$17.2M Sell
94,959
-2,231
-2% -$445K 0.01% 2084
2020
Q4 		$10.8M Buy
97,190
+5,090
+6% +$541K ﹤0.01% 2248
2020
Q3 		$9.98M Buy
+92,100
New +$11.2M ﹤0.01% 2194
2015
Q4 		– Sell
-15,272
Closed -$2.16M – 3339
2015
Q3 		$2.16M Buy
+15,272
New +$3.42M ﹤0.01% 2795

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors's NVAX Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Novavax (NVAX) stake by 6.2% in Q1 2026, buying an estimated $6.25K and bringing the position to 11,847 shares worth $96.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3123.

Dimensional Fund Advisors first reported a position in NVAX in Q3 2015 and has held it in 11 quarters since. The position peaked at $21.8M in Q2 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Dimensional Fund Advisors held 11,847 shares of Novavax worth $96.4K as of Q1 2026.
  • Dimensional Fund Advisors bought 689 Novavax shares in Q1 2026, an estimated $6.25K.
  • Novavax made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #3123 holding.
  • Dimensional Fund Advisors first reported a position in Novavax in Q3 2015 and has held it in 11 quarters since.
  • Dimensional Fund Advisors's Novavax position peaked at $21.8M in Q2 2021.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.